These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33942732)

  • 1. [Active surveillance for testicular tumors: adherence and safety.].
    Rico L; Blas L; Vitagliano G; Villasante N; Rios Pita H; Contreras P; Lopez FM; Ameri C
    Arch Esp Urol; 2021 May; 74(4):397-403. PubMed ID: 33942732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing Practice Evaluation-Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols-Experience From a Supraregional Center.
    Tyrrell HEJ; Church DN; Joseph J; Traill ZC; Sullivan ME; Tuthill MH; Verrill CL; Pintus EP; Dallas NL; Rogers PB; Redgwell J; Protheroe AS
    Clin Genitourin Cancer; 2018 Jun; 16(3):240-244. PubMed ID: 29336917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era.
    Yuasa T; Inoshita N; Tanaka H; Urakami S; Yamamoto S; Fujii Y; Masuda H; Fukui I; Ishikawa Y; Yonese J
    Int J Clin Oncol; 2015 Dec; 20(6):1198-202. PubMed ID: 25893862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surveillance of stage I testicular seminoma: 20 years oncological results].
    Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
    Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
    Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
    J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance-A systematic review.
    Zengerling F; Kunath F; Jensen K; Ruf C; Schmidt S; Spek A
    Urol Oncol; 2018 Oct; 36(10):448-458. PubMed ID: 28712790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
    Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
    World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
    Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
    Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002.
    Tyldesley S; Voduc D; McKenzie M; Duncan G; Liu M; Wu D
    Urology; 2006 Mar; 67(3):594-8. PubMed ID: 16527585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).
    Tandstad T; Ståhl O; Dahl O; Haugnes HS; Håkansson U; Karlsdottir Å; Kjellman A; Langberg CW; Laurell A; Oldenburg J; Solberg A; Söderström K; Stierner U; Cavallin-Ståhl E; Wahlqvist R; Wall N; Cohn-Cedermark G;
    Ann Oncol; 2016 Jul; 27(7):1299-304. PubMed ID: 27052649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
    Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G
    J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide cohort study of stage I seminoma patients followed on a surveillance program.
    Mortensen MS; Lauritsen J; Gundgaard MG; Agerbæk M; Holm NV; Christensen IJ; von der Maase H; Daugaard G
    Eur Urol; 2014 Dec; 66(6):1172-8. PubMed ID: 25064686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
    Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
    J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of adjuvant irradiation or surveillance in stage I testicular seminoma.
    Miki T; Nonomura N; Saiki S; Kotake T
    Int J Urol; 1998 Jul; 5(4):357-60. PubMed ID: 9712444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
    Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
    J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study.
    Aparicio J; Sánchez-Muñoz A; Gumà J; Domenech M; Meana JA; García-Sánchez J; Bastús R; Gironés R; González-Billalabeitia E; Sagastibelza N; Ochenduszko S; Sánchez A; Terrasa J; Germà-Lluch JR; García Del Muro X;
    Oncology; 2018; 95(1):8-12. PubMed ID: 29587278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma.
    Choo R; Thomas G; Woo T; Lee D; Kong B; Iscoe N; Danjoux C; Klotz L; Morton G; Chander S
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):736-40. PubMed ID: 15708251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.